Clinical Trials Browser

Phase 1 × Unknown × donafenib × Clear all

NCT04472858 2022-11-29

A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumor

NCT04059874 2019-08-16

Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung